308824
Adapting Innovations for Safety Net Practices: Strategies and Opportunities to STOP Colon Cancer in Priority Populations
Relevance: Nationally, Latinos represent 34% of the 20 million patients served annually by safety net clinics.
Methods: The study will assess effectiveness of a systems-based colorectal cancer screening intervention in safety net clinics in Oregon and Northern California. The study has two phases: Phase 1 is a pilot phase in which we developed and tested our electronic health record (EHR) tools, and Phase 2 is a larger two-arm cluster-randomized comparative-effectiveness study involving 26 clinics (estimated population aged 50-74 = 30,000). The intervention is an automated, data-driven program to identify patients due for colorectal cancer screening and mail fecal immunochemical test (FIT) kits to them.
Results: Phase 1 findings showed an overall 38 percentage point increase in colorectal cancer screening in intervention, compared to Usual Care, clinics. If successful, the Phase 2 program will prompt 12,000 patients to undergo FIT testing, and will detect about 40 new cancers.
Conclusion: This large-scale pragmatic study will assess effectiveness of a colorectal cancer screening program that will enroll a broad range of patients, including Latinos. Our EHR tools will realize a sustained impact on how screening is delivered in safety net clinics.
Learning Areas:
Communication and informaticsDiversity and culture
Implementation of health education strategies, interventions and programs
Learning Objectives:
Describe adaptations of an automated, data-driven colorectal cancer screening intervention for safety net practices
Keyword(s): Cancer Prevention and Screening, Practice-Based Research
Qualified on the content I am responsible for because: I am a graduate student interning with Gloria Coronado, PhD and I have contributed to the STOP CRC project in various ways (e.g. literature review, transcribing interviews, etc.). I do not have any relationship(s) to disclose.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.